Nutrients,
Journal Year:
2020,
Volume and Issue:
12(5), P. 1466 - 1466
Published: May 19, 2020
The
novel
coronavirus
disease
(COVID-19)
pandemic
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
has
engulfed
the
world,
affecting
more
than
180
countries.
As
a
result,
there
been
considerable
economic
distress
globally
and
significant
loss
of
life.
Sadly,
vulnerable
immunocompromised
in
our
societies
seem
to
be
susceptible
COVID-19
complications.
Global
public
health
bodies
governments
have
ignited
strategies
issued
advisories
on
various
handwashing
hygiene
guidelines,
social
distancing
strategies,
and,
most
extreme
cases,
some
countries
adopted
“stay
place”
or
lockdown
protocols
prevent
spread.
Notably,
are
several
risk
factors
for
infection.
These
include
presence
poor
nutritional
status
pre-existing
noncommunicable
diseases
(NCDs)
such
as
diabetes
mellitus,
chronic
lung
diseases,
cardiovascular
(CVD),
obesity,
other
that
render
patient
immunocompromised.
characterized
systemic
inflammation,
which
may
common
feature
these
NCDs,
outcomes
against
COVID-19.
In
this
review,
we
discuss
anti-inflammatory
therapies
currently
under
investigation
intended
dampen
cytokine
storm
infections.
Furthermore,
role
diet
lifestyle
is
considered,
it
known
affect
infections
play
This
review
speculates
importance
nutrition
mitigation
strategy
support
immune
function
amid
pandemic,
identifying
food
groups
key
nutrients
Journal of Medical Virology,
Journal Year:
2020,
Volume and Issue:
92(4), P. 424 - 432
Published: Jan. 25, 2020
Coronaviruses
(CoVs)
are
by
far
the
largest
group
of
known
positive-sense
RNA
viruses
having
an
extensive
range
natural
hosts.
In
past
few
decades,
newly
evolved
have
posed
a
global
threat
to
public
health.
The
immune
response
is
essential
control
and
eliminate
CoV
infections,
however,
maladjusted
responses
may
result
in
immunopathology
impaired
pulmonary
gas
exchange.
Gaining
deeper
understanding
interaction
between
innate
systems
hosts
shed
light
on
development
persistence
inflammation
lungs
hopefully
can
reduce
risk
lung
caused
CoVs.
this
review,
we
provide
update
infections
relevant
diseases,
particularly
host
defense
against
CoV-induced
tissue,
as
well
role
system
pathogenesis
clinical
treatment.
Clinical Microbiology Reviews,
Journal Year:
2020,
Volume and Issue:
33(4)
Published: June 23, 2020
In
recent
decades,
several
new
diseases
have
emerged
in
different
geographical
areas,
with
pathogens
including
Ebola
virus,
Zika
Nipah
and
coronaviruses
(CoVs).
Recently,
a
type
of
viral
infection
Wuhan
City,
China,
initial
genomic
sequencing
data
this
virus
do
not
match
previously
sequenced
CoVs,
suggesting
novel
CoV
strain
(2019-nCoV),
which
has
now
been
termed
severe
acute
respiratory
syndrome
CoV-2
(SARS-CoV-2).
Although
coronavirus
disease
2019
(COVID-19)
is
suspected
to
originate
from
an
animal
host
(zoonotic
origin)
followed
by
human-to-human
transmission,
the
possibility
other
routes
should
be
ruled
out.
ACS Nano,
Journal Year:
2020,
Volume and Issue:
14(4), P. 5135 - 5142
Published: April 15, 2020
Coronavirus
disease
2019
(COVID-19)
is
a
newly
emerging
human
infectious
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2,
previously
called
2019-nCoV).
Based
on
the
rapid
increase
in
rate
of
infection,
World
Health
Organization
(WHO)
has
classified
COVID-19
outbreak
as
pandemic.
Because
no
specific
drugs
or
vaccines
for
are
yet
available,
early
diagnosis
and
management
crucial
containing
outbreak.
Here,
we
report
field-effect
transistor
(FET)-based
biosensing
device
detecting
SARS-CoV-2
clinical
samples.
The
sensor
was
produced
coating
graphene
sheets
FET
with
antibody
against
spike
protein.
performance
determined
using
antigen
protein,
cultured
virus,
nasopharyngeal
swab
specimens
from
patients.
Our
could
detect
protein
at
concentrations
1
fg/mL
phosphate-buffered
saline
100
transport
medium.
In
addition,
successfully
detected
culture
medium
(limit
detection
[LOD]:
1.6
×
101
pfu/mL)
samples
(LOD:
2.42
102
copies/mL).
Thus,
have
fabricated
promising
biosensor
SARS-CoV-2;
our
highly
sensitive
immunological
diagnostic
method
that
requires
sample
pretreatment
labeling.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: July 12, 2021
Abstract
Cancer
development
and
its
response
to
therapy
are
regulated
by
inflammation,
which
either
promotes
or
suppresses
tumor
progression,
potentially
displaying
opposing
effects
on
therapeutic
outcomes.
Chronic
inflammation
facilitates
progression
treatment
resistance,
whereas
induction
of
acute
inflammatory
reactions
often
stimulates
the
maturation
dendritic
cells
(DCs)
antigen
presentation,
leading
anti-tumor
immune
responses.
In
addition,
multiple
signaling
pathways,
such
as
nuclear
factor
kappa
B
(NF-kB),
Janus
kinase/signal
transducers
activators
transcription
(JAK-STAT),
toll-like
receptor
(TLR)
cGAS/STING,
mitogen-activated
protein
kinase
(MAPK);
factors,
including
cytokines
(e.g.,
interleukin
(IL),
interferon
(IFN),
necrosis
(TNF)-α),
chemokines
C-C
motif
chemokine
ligands
(CCLs)
C-X-C
(CXCLs)),
growth
factors
vascular
endothelial
(VEGF),
transforming
(TGF)-β),
inflammasome;
well
metabolites
prostaglandins,
leukotrienes,
thromboxane,
specialized
proresolving
mediators
(SPM),
have
been
identified
pivotal
regulators
initiation
resolution
inflammation.
Nowadays,
local
irradiation,
recombinant
cytokines,
neutralizing
antibodies,
small-molecule
inhibitors,
DC
vaccines,
oncolytic
viruses,
TLR
agonists,
SPM
developed
specifically
modulate
in
cancer
therapy,
with
some
these
already
undergoing
clinical
trials.
Herein,
we
discuss
crosstalk
between
processes.
We
also
highlight
potential
targets
for
harnessing
cancer.
Infectious Diseases of Poverty,
Journal Year:
2020,
Volume and Issue:
9(1)
Published: April 28, 2020
Since
its
discovery
in
December
2019,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
infected
more
than
180
000
people
worldwide
and
caused
150
deaths
as
of
April
16,
2020.
SARS-CoV-2,
which
is
the
virus
causing
disease
2019
(COVID-19),
uses
angiotensin-converting
enzyme
(ACE2)
a
cell
receptor
to
invade
human
cells.
Thus,
ACE2
key
understanding
mechanism
SARS-CoV-2
infection.
This
study
investigate
expression
various
tissues
order
provide
insights
into
infection.We
compared
levels
across
31
normal
between
males
females
younger
(ages
≤
49
years)
older
>
persons
using
two-sided
Student's
t
test.
We
also
investigated
correlations
immune
signatures
Pearson's
correlation
test.ACE2
were
highest
small
intestine,
testis,
kidneys,
heart,
thyroid,
adipose
tissue,
lowest
blood,
spleen,
bone
marrow,
brain,
blood
vessels,
muscle.
showed
medium
lungs,
colon,
liver,
bladder,
adrenal
gland.
was
not
differentially
expressed
or
any
tissue.
In
skin,
digestive
system,
positively
associated
with
both
females.
thyroid
negatively
females,
respectively,
lungs
they
had
positive
negative
groups,
respectively.Our
data
indicate
that
may
infect
other
aside
from
different
sexes,
ages,
races
equally.
The
host
responses
infection
partially
explain
why
young
old
this
have
markedly
distinct
severity.
provides
new
role
pandemic.
Gut,
Journal Year:
2020,
Volume and Issue:
69(6), P. 1002 - 1009
Published: March 24, 2020
Objective
The
SARS-CoV-2-infected
disease
(COVID-19)
outbreak
is
a
major
threat
to
human
beings.
Previous
studies
mainly
focused
on
Wuhan
and
typical
symptoms.
We
analysed
74
confirmed
COVID-19
cases
with
GI
symptoms
in
the
Zhejiang
province
determine
epidemiological,
clinical
virological
characteristics.
Design
hospital
patients
were
admitted
from
17
January
2020
8
February
2020.
Epidemiological,
demographic,
clinical,
laboratory,
management
outcome
data
of
using
multivariate
analysis
for
risk
severe/critical
type.
Bioinformatics
used
analyse
features
SARS-CoV-2
province.
Results
Among
enrolled
651
patients,
(11.4%)
presented
at
least
one
symptom
(nausea,
vomiting
or
diarrhoea),
average
age
46.14
years,
4-day
incubation
period
10.8%
had
pre-existing
liver
disease.
Of
symptoms,
(22.97%)
23
(31.08%)
types
family
clustering,
respectively,
significantly
higher
than
those
without
47
(8.14%)
118
(20.45%).
29
(39.19%),
(31.08%),
(10.81%)
16
(21.62%)
rates
fever
>38.5°C,
fatigue,
shortness
breath
headache,
respectively.
Low-dose
glucocorticoids
antibiotics
administered
14.86%
41.89%
Sputum
production
increased
lactate
dehydrogenase/glucose
levels
factors
showed
sequence
mutation
m
6
A
methylation
changed
binding
capacity
ACE2.
Conclusion
report
novel
outside
Wuhan.
Attention
non-classic
should
increase
protect
health
providers.
Emerging Microbes & Infections,
Journal Year:
2020,
Volume and Issue:
9(1), P. 1123 - 1130
Published: Jan. 1, 2020
Since
the
outbreak
of
coronavirus
disease
2019
(COVID-19)
in
Wuhan,
China,
it
has
rapidly
spread
across
many
other
countries.
While
majority
patients
were
considered
mild,
critically
ill
involving
respiratory
failure
and
multiple
organ
dysfunction
syndrome
are
not
uncommon,
which
could
result
death.
We
hypothesized
that
cytokine
storm
is
associated
with
severe
outcome.
enrolled
102
COVID-19
who
admitted
to
Renmin
Hospital
(Wuhan,
China).
All
classified
into
moderate,
critical
groups
according
their
symptoms.
45
control
samples
healthy
volunteers
also
included.
Inflammatory
cytokines
C-Reactive
Protein
(CRP)
profiles
serum
analyzed
by
specific
immunoassays.
Results
showed
have
higher
level
(TNF-α,
IFN-γ,
IL-2,
IL-4,
IL-6
IL-10)
CRP
than
individuals.
Within
patients,
IL-10
levels
significantly
group
(n
=
17)
moderate
42)
43)
group.
The
positively
correlated
amount
(r
0.41,
P
<
0.01).
Using
univariate
logistic
regression
analysis,
found
be
predictive
severity
receiver
operating
curve
analysis
further
confirm
this
(AUC
0.841,
0.822
respectively).
Our
indicated
more
development.
Among
them,
can
used
as
predictors
for
fast
diagnosis
risk
deterioration.
Given
high
induced
SARS-CoV-2,
treatment
reduce
inflammation-related
lung
damage
critical.